Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.

Montoya JG, Kogelnik AM, Bhangoo M, Lunn MR, Flamand L, Merrihew LE, Watt T, Kubo JT, Paik J, Desai M.

J Med Virol. 2013 Dec;85(12):2101-9. doi: 10.1002/jmv.23713. Epub 2013 Aug 19.

2.

Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.

Watt T, Oberfoell S, Balise R, Lunn MR, Kar AK, Merrihew L, Bhangoo MS, Montoya JG.

J Med Virol. 2012 Dec;84(12):1967-74. doi: 10.1002/jmv.23411.

5.

A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.

Lerner AM, Beqaj SH, Deeter RG, Dworkin HJ, Zervos M, Chang CH, Fitzgerald JT, Goldstein J, O'Neill W.

Drugs Today (Barc). 2002 Aug;38(8):549-61. Review.

PMID:
12582420
6.

Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein-Barr virus.

Hierro L, Díez-Dorado R, Díaz C, De la Vega A, Frauca E, Camarena C, Muñoz-Bartolo G, González de Zárate A, López Santamaría M, Jara P.

Liver Transpl. 2008 Aug;14(8):1185-93. doi: 10.1002/lt.21498.

7.

Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.

Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT.

In Vivo. 2007 Sep-Oct;21(5):707-13.

8.

Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.

Sairenji T, Yamanishi K, Tachibana Y, Bertoni G, Kurata T.

Intervirology. 1995;38(5):269-73.

PMID:
8724857
9.

Lessons from a pilot study of transfer factor in chronic fatigue syndrome.

De Vinci C, Levine PH, Pizza G, Fudenberg HH, Orens P, Pearson G, Viza D.

Biotherapy. 1996;9(1-3):87-90.

PMID:
8993764
10.

Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.

Cameron B, Flamand L, Juwana H, Middeldorp J, Naing Z, Rawlinson W, Ablashi D, Lloyd A.

J Med Virol. 2010 Oct;82(10):1684-8. doi: 10.1002/jmv.21873.

PMID:
20827765
11.

A therapeutic trial of valganciclovir in patients with uveitis and positive Epstein-Barr virus early antigen D IgG titers.

Boonsopon S, Maghsoudlou A, Kombo NE, Foster CS.

Eur J Ophthalmol. 2016 Jan-Feb;26(1):30-5. doi: 10.5301/ejo.5000673. Epub 2015 Sep 2.

PMID:
26350994
12.

Human Placental Extract as a Subcutaneous Injection Is Effective in Chronic Fatigue Syndrome: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.

Park SB, Kim KN, Sung E, Lee SY, Shin HC.

Biol Pharm Bull. 2016 May 1;39(5):674-9. doi: 10.1248/bpb.b15-00623. Epub 2016 Feb 25.

13.

Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.

Lerner AM, Ariza ME, Williams M, Jason L, Beqaj S, Fitzgerald JT, Lemeshow S, Glaser R.

PLoS One. 2012;7(11):e47891. doi: 10.1371/journal.pone.0047891. Epub 2012 Nov 14.

14.

Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.

Casper C, Krantz EM, Corey L, Kuntz SR, Wang J, Selke S, Hamilton S, Huang ML, Wald A.

J Infect Dis. 2008 Jul 1;198(1):23-30. doi: 10.1086/588820.

15.

Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir.

Bounaadja L, Piret J, Goyette N, Boivin G.

J Clin Virol. 2013 Sep;58(1):279-82. doi: 10.1016/j.jcv.2013.06.024. Epub 2013 Jul 16.

PMID:
23871165
16.

[Chronic fatigue syndrome--study of 51 cases treated at the Second Tokyo National Hospital].

Nishikai M.

Nihon Rinsho. 1992 Nov;50(11):2641-7. Japanese.

PMID:
1337560
17.
18.
19.

Diagnostic evaluation of 2', 5'-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan.

Ikuta K, Yamada T, Shimomura T, Kuratsune H, Kawahara R, Ikawa S, Ohnishi E, Sokawa Y, Fukushi H, Hirai K, Watanabe Y, Kurata T, Kitani T, Sairenji T.

Microbes Infect. 2003 Oct;5(12):1096-102.

PMID:
14554250
20.

Human herpesviruses in chronic fatigue syndrome.

Wallace HL 2nd, Natelson B, Gause W, Hay J.

Clin Diagn Lab Immunol. 1999 Mar;6(2):216-23.

Supplemental Content

Support Center